-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$91.6920.12% Upside
Bio-Techne Corporation Frequently Asked Questions
-
What analysts cover Bio-Techne Corporation?
Bio-Techne Corporation has been rated by research analysts at Robert W. Baird, KeyBanc, Scotiabank, Deutsche Bank, Citigroup, RBC Capital in the past 90 days.